
SNAP-810 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
SNAP-8, explained simply
A cosmetic peptide examined in skin products, often alongside other ingredients.
Research area
Cosmetics and skin
How it works
SNAP-8, or acetyl octapeptide-3, is investigated in cosmetic formulas with a proposed mechanism involving the SNARE complex.
Why it matters
The active concentration and finished formula matter more than the ingredient name alone.
What has been observed
Multi-ingredient serums and patches have been studied for wrinkles and skin quality.
Effects and points to consider
Effects of combined products cannot be attributed to SNAP-8 alone; a new formula's safety and stability need separate evaluation.
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 10 mg SNAP-8 |
|---|
Whole 10 mg Vial Concentration Calculator
| Final Batch | Active Peptide | Active % w/w | ppm | Research Context |
|---|---|---|---|---|
| 30 g | 10 mg | 0.0333% w/w | 333 ppm | Calculation example |
| 50 g | 10 mg | 0.0200% w/w | 200 ppm | Calculation example |
| 100 g | 10 mg | 0.0100% w/w | 100 ppm | Calculation example |
| 333.3 g | 10 mg | 0.0030% w/w | 30 ppm | Mid-range calculation |
Small-Batch SNAP-8 Research Calculations
| Final Batch | 0.0015% Active | 0.0030% Active | 0.0050% Active |
|---|---|---|---|
| 30 g | 0.45 mg | 0.90 mg | 1.50 mg |
| 50 g | 0.75 mg | 1.50 mg | 2.50 mg |
| 100 g | 1.50 mg | 3.00 mg | 5.00 mg |
Worked 1 mg/mL Stock Measurement Example
| Final Batch | Stock for 0.0015% | Stock for 0.0030% | Stock for 0.0050% |
|---|---|---|---|
| 30 g | 0.45 mL | 0.90 mL | 1.50 mL |
| 50 g | 0.75 mL | 1.50 mL | 2.50 mL |
| 100 g | 1.50 mL | 3.00 mL | 5.00 mL |
Human SNAP-8 Research Formulations
| Study | Formulation | Schedule | Design Context | Evidence Limit |
|---|---|---|---|---|
| Shin et al. (2024)[1] | 350 micrometer dissolving patch with 0.03% SNAP-8, 5% AA2G, 4% cyclic LPA, and 90% HA | Overnight nightly through day 14, then every third day through day 28 | 24 enrolled and 21 completed a split-face active-versus-placebo comparison | Combination device; SNAP-8’s independent contribution cannot be isolated |
| Avcil et al. (2020)[2] | HA microneedle patch with SNAP-8, other peptides, adenosine, and seaweed extracts | 12-week study | Fine lines, hydration, dermal density, thickness, and tolerability measures | Multi-active product; SNAP-8 concentration was not disclosed in the abstract |
| Draelos et al. (2016)[3] | Multi-peptide serum containing SNAP-8 within a supporting skincare regimen | Morning and evening for 12 weeks after a 2-week washout | 29 women; investigator grading and participant questionnaires | Open label, no control, multiple peptides and supporting products |
| Moy et al. (2023)[4] | Proprietary multi-peptide facial serum containing acetyl octapeptide-3 | Twice daily for 12 weeks | 31 women completed dermatologist grading, imaging, hydration, and questionnaires | Uncontrolled, multi-ingredient, and company funded |
Supplies needed


Sterile alcohol swabs
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.